Unprecedented improvement of ovarian cancer survival in BRCA-positive patients
The drug olaparib delays the recurrence of advanced ovarian cancer in woman who carry the BRCA gene.
Read more about 'Unprecedented improvement of ovarian cancer survival in BRCA-positive patients'...
Posted in BRCA; Posted 6 years ago by Andreas Obermair
Recent Posts
- Myths about the HPV vaccine dispelled
- Advocacy and Awareness: Using Your Voice for Change
- What are the pros and cons of having treatment in the public vs private hospital system?
- Will I need hormone replacement therapy (HRT) after a hysterectomy?
- Navigating the changes: Understanding surgical menopause